Cargando…

Biochemical and Anti-Triple Negative Metastatic Breast Tumor Cell Properties of Psammaplins

Breast tumors reprogram their cellular metabolism, nutrient uptake, and utilization-associated biochemical processes. These processes become further transformed as genetically predisposed metastatic breast tumor cells colonize specific organs. Breast tumor cells often metastasize to the brain, bone,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yu-Dong, Li, Jun, Du, Lin, Mahdi, Fakhri, Le, Thuy P., Chen, Wei-Lun, Swanson, Steven M., Watabe, Kounosuke, Nagle, Dale G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265740/ https://www.ncbi.nlm.nih.gov/pubmed/30423844 http://dx.doi.org/10.3390/md16110442

Ejemplares similares

Synthesis of the Marine Bromotyrosine Psammaplin F and Crystal Structure of a Psammaplin A Analogue
por: Yang, Qianjiao, et al.
Publicado: (2010)

Targeting Histone Methyltransferase DOT1L by a Novel Psammaplin A Analog Inhibits Growth and Metastasis of Triple-Negative Breast Cancer
por: Byun, Woong Sub, et al.
Publicado: (2019)

Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors
por: Baud, Matthias G J, et al.
Publicado: (2013)

Cytotoxicity of psammaplin A from a two-sponge association may correlate with the inhibition of DNA replication
por: Jiang, Yahong, et al.
Publicado: (2004)

Inhibition of the Quorum Sensing System, Elastase Production and Biofilm Formation in Pseudomonas aeruginosa by Psammaplin A and Bisaprasin
por: Oluwabusola, Emmanuel T., et al.
Publicado: (2022)

Marine-Derived Natural Lead Compound Disulfide-Linked Dimer Psammaplin A: Biological Activity and Structural Modification
por: Jing, Qinxue, et al.
Publicado: (2019)

Synthesis and Preliminary Biological Evaluation of Two Fluoroolefin Analogs of Largazole Inspired by the Structural Similarity of the Side Chain Unit in Psammaplin A
por: Zhang, Bingbing, et al.
Publicado: (2019)

Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative and HER2-enriched breast cancers
por: Sirkisoon, Sherona R., et al.
Publicado: (2018)

Coix Seed Oil Exerts an Anti–Triple-Negative Breast Cancer Effect by Disrupting miR-205/S1PR1 Axis
por: Fang, Ting, et al.
Publicado: (2020)

Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast Cancer
por: Pauls, Mehrnoosh, et al.
Publicado: (2022)

Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells
por: Abdullah, Mashan L., et al.
Publicado: (2018)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021)

Anti-metastatic action of an N(4)-aryl substituted thiosemicarbazone on advanced triple negative breast cancer.
por: Sólimo, A.M., et al.
Publicado: (2020)

Metastatic and triple-negative breast cancer: challenges and treatment options
por: Al-Mahmood, Sumayah, et al.
Publicado: (2018)

Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer
por: Saravia, César H, et al.
Publicado: (2019)

How I treat metastatic triple-negative breast cancer
por: Caparica, Rafael, et al.
Publicado: (2019)

Overview of recent advances in metastatic triple negative breast cancer
por: O'Reilly, David, et al.
Publicado: (2021)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021)

Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
por: Heeke, Arielle L., et al.
Publicado: (2021)

Emerging treatment strategies for metastatic triple-negative breast cancer
por: Huppert, Laura A., et al.
Publicado: (2022)

Discovery and characterization of an immunogenic neoantigen in a patient with metastatic triple negative breast cancer
por: Assadipour, Yasmine, et al.
Publicado: (2015)

The Confounders of Cancer Immunotherapy: Roles of Lifestyle, Metabolic Disorders and Sociological Factors
por: Deshpande, Ravindra Pramod, et al.
Publicado: (2020)

Metabolism in the progression and metastasis of brain tumors
por: Tyagi, Abhishek, et al.
Publicado: (2022)

Circulating tumor cells in non-metastatic triple-negative breast cancer
por: Karhade, Mandar, et al.
Publicado: (2014)

A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer
por: Zeichner, Simon B., et al.
Publicado: (2016)

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
por: Cazzaniga, M. E., et al.
Publicado: (2017)

Practical consensus recommendations on management of triple-negative metastatic breast cancer
por: Rangarao, R., et al.
Publicado: (2018)

Sacituzumab Govitecan for Treatment of Refractory Triple-Negative Metastatic Breast Cancer
por: Fleming, Patrick J., et al.
Publicado: (2021)

Optimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast Carcinoma
por: Sflomos, George, et al.
Publicado: (2023)

Standard of Care and Promising New Agents for Triple Negative Metastatic Breast Cancer
por: Mancini, Patrizia, et al.
Publicado: (2014)

Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key
por: Rabanal, Connie, et al.
Publicado: (2017)

Leptomeningeal Carcinomatosis: A Case Report of Metastatic Triple-negative Breast Adenocarcinoma
por: Parker, Nathaniel, et al.
Publicado: (2019)

Cytoskeletal and extracellular matrix proteins as markers for metastatic triple negative breast cancer
por: Mohammed, Mohammed Elimam Ahamed, et al.
Publicado: (2019)

Stromal Characteristics and Impact on New Therapies for Metastatic Triple-Negative Breast Cancer
por: Fertal, Shelby A., et al.
Publicado: (2022)

Palmatine Attenuates Metastatic Lung Colonization of Triple Negative Breast Cancer Cells
por: Ativui, Selase, et al.
Publicado: (2022)

Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything
por: Capici, Serena, et al.
Publicado: (2022)

Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches
por: Geurts, Veerle, et al.
Publicado: (2023)

In vitro and in vivo anti-cancer effects of hibernating common carp (Cyprinus carpio) plasma on metastatic triple-negative breast cancer
por: Golpich, Mojtaba, et al.
Publicado: (2022)

Targeting Tumor Acidosis and Regulatory T Cells Unmasks Anti-Metastatic Potential of Local Tumor Ablation in Triple-Negative Breast Cancer
por: Nief, Corrine A., et al.
Publicado: (2022)

Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer
por: O’Flanagan, Ciara H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_083v0cgqm70qai1s0emafcfu2n